Catalyst Biosciences, Inc.

CBIO

1 Followers
$0.51 -2.65% -$0.01
N/A
Upcoming Earnings
 
Market Cap.
 
P/E
Loading...

My Notes

Začít psát

Profile

Catalyst Biosciences, Inc. (CBIO) is a biotechnology company specializing in the development of therapeutic therapies for patients with rare and life-threatening bleeding disorders. The company focuses on innovative therapeutic approaches that can improve blood clotting and provide effective treatment for patients. Catalyst Biosciences develops drugs for diseases such as hemophilia and von Willebrand disease. With the growing awareness of the need for treatment of these rare disorders and the effort to improve the quality of life for patients, Catalyst Biosciences, Inc. has the potential for sustained growth. Catalyst Biosciences, Inc. (CBIO) shares might be an interesting choice for investors seeking involvement in the biotechnology and therapeutic therapies for bleeding disorders.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade